Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Antares Pharma, Inc.
Plans at pharmaceutical firm continue following move of shares to OTCBB
July 30th, 2003
Antares Pharma, Inc., (ANTR) announced that it is continuing its program to deliver on its business plan as articulated prior to the July 1 transfer of its shares from the NASDAQ SmallCap Market to the OTC Bulletin board (OTCBB). Specifically, this includes a goal to close on two significant business transactions for licenses to its technology before year end and the intent to secure sufficient financing to enable the company to achieve short-term plans. Roger G. Harrison, Antares Pharma's CEO and president, indicated, "While the delisting of our securities from the NASDAQ SmallCap Market is a disappointment, this action does not change our business...
Source: Biotech Week (2003-07-30)
|
